Internal Medicine Grand Rounds-15491-------11/19/2012, Stanton Gerber Hall
Zhi Q. Yao, M.D., Ph.D.
Dr. Yao reports there is NOT a financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent
COI in the context of this presentation.
This Continuing Medical Education activity has not received support from any commercial source.
'PD-1, SOCS-1, TIM-3 in HCV Infection-Why We Care?'
How well did this activity meet the stated learning objective?
ExcellentAbove AverageAverageBelow AveragePoor
Learn how HCV employ negative signaling molecules for chronic infection          
Discuss why we care about this- application in the HCV pathogenesis, treatment, and vaccine development          
Please rate this presentation:
ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
YesNo
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
    
  
What do you expect to find PD-1 and/or TIM-3 expression levels on T cells from HCV patients?
A). Increased.----B). Decreased.----C). Unchanged.
ABC
Correct answer is: A      
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME cmeadean@etsu.edu or 423.439.8081.
Form Revised 9-2012